Healthcare Sector Roundup: Cardium Therapeutics (NYSE:CXM), Rigel Pharmaceuticals (NASDAQ:RIGL) – CXM, RIGL, AZN, RIGL, AMRN, PFE

Healthcare sector finished in red land on Friday trading session and sector plunged -0.58%. If we consider key percentage decliners so Rigel Pharmaceuticals, Inc (NASDAQ:RIGL) and Amarin Corporation plc (ADR) (NASDAQ:AMRN) were key stocks while most active stock was Pfizer Inc (NYSE:PFE).

Cardium Therapeutics Inc (NYSEAMEX:CXM) reported a net loss of $2.0 million or $0.02 a share for fourth-quarter, contrasted against a net loss of $2.1 million or $0.02 a share in fiscal Q4 of previous year.
The company also announced in separate statement that it has made into a definitive accord with a single institutional healthcare fund managed by Sabby Management LLC, the firm’s biggest shareholder, for a financing of around $4.0 million in gross proceeds.

Cardium Therapeutics Inc’s YTD performance was recorded as -40.00% while its market capitalization was $14.73 million. The company has P/B ratio of 1.90. Institutional ownership owns 8.69% shares of the company while beta factor, which is used to measure riskiness of the security, was 2.27.

Rigel Pharmaceuticals, Inc (NASDAQ:RIGL) is facing investor fears after its partner, pharmaceutical giant AstraZeneca plc (ADR) (NYSE:AZN) announced less-than-stellar results about their drug candidate, fostamatinib. Rigel Pharmaceuticals is a small clinical-stage drug developer.

Rigel Pharmaceuticals, Inc. has market capitalization of $392.13 billion. Its current ratio was 24.78 while its shares were lagging behind SMA50 with -34.14. The company offered earnings per share of -1.32 while its 94.01 million shares were outstanding. YTD performance of the stock was 11.13%.

AstraZeneca plc (ADR) has the market capitalization of $62.94 billion. The company’s EPS was 4.98 while its 1.25 billion shares were outstanding. Its institutional ownership was 8.47%. Shares of the company were moving ahead of SMA50 with 7.93% while its YTD performance was 11.13%.

DO NOT TRADE ANY STOCK WITHOUT LEVEL 2 STOCK QUOTES! delivers it's user with the most in-depth Level 2 Quotation System available on the Planet! NO Downloads, NO Widgets, NO Plugins required! Stay on TOP of your trades with! CLICK HERE TO START YOUR FREE 30-DAY TRIAL

This entry was posted in Healthcare, Latest Headlines and tagged , , , , , , , , , , , , , , . Bookmark the permalink.